Skip to main content
Premium Trial:

Request an Annual Quote

Zyomyx Buys 903e Plasma Etch Tool from Tegal for Help in Protein-Biochip Development

NEW YORK, Dec. 30 - Tegal said it has sold  Zyomyx one of its 903e plasma etch systems, and said the company expects to install the tool in early January.

 

Zyomyx will use the tool to create protein-profiling biochips, Tegal said in a statement last week.

 

The 903e is used to manufacture biochip components used in high-throughput, massively parallel protein-analysis systems, according to Tegal. The deal marks the first time the two companies have worked together.

 

Click here for more information.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.